Inspire Investing LLC Has $352,000 Stock Holdings in Maximus, Inc. (NYSE:MMS)

Inspire Investing LLC lowered its holdings in shares of Maximus, Inc. (NYSE:MMS) by 3.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,112 shares of the health services provider’s stock after selling 131 shares during the period. Inspire Investing LLC’s holdings in Maximus were worth $352,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Rise Advisors LLC raised its holdings in shares of Maximus by 1,445.0% during the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 289 shares during the period. GAMMA Investing LLC increased its position in Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after buying an additional 238 shares in the last quarter. Blue Trust Inc. raised its stake in Maximus by 201.5% during the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock worth $33,000 after buying an additional 262 shares during the period. Kapitalo Investimentos Ltda bought a new position in Maximus in the fourth quarter worth approximately $52,000. Finally, Archer Investment Corp grew its stake in Maximus by 8,788.9% in the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock valued at $69,000 after acquiring an additional 791 shares during the period. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Performance

Shares of MMS stock opened at $89.98 on Monday. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. The firm has a fifty day simple moving average of $89.80 and a two-hundred day simple moving average of $86.15. Maximus, Inc. has a 12 month low of $72.39 and a 12 month high of $93.97. The firm has a market capitalization of $5.47 billion, a PE ratio of 23.62 and a beta of 0.76.

Maximus (NYSE:MMS) last released its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.27. The business had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a net margin of 5.59% and a return on equity of 20.91%. The firm’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.78 earnings per share. Analysts forecast that Maximus, Inc. will post 6.12 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend was Thursday, August 15th. Maximus’s dividend payout ratio (DPR) is presently 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.